e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Variable utility of mosaic attenuation to distinguish fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis
Joseph Barnett, Philip L. Molyneaux, Bhavin Rawal, Rezaur Abdullah, Samanjit S. Hare, Rama Vancheeswaran, Sujal R. Desai, Toby M. Maher, Athol U. Wells, Anand Devaraj
Source:
Eur Respir J, 54 (1) 1900531; 10.1183/13993003.00531-2019
Journal Issue:
July
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Joseph Barnett, Philip L. Molyneaux, Bhavin Rawal, Rezaur Abdullah, Samanjit S. Hare, Rama Vancheeswaran, Sujal R. Desai, Toby M. Maher, Athol U. Wells, Anand Devaraj. Variable utility of mosaic attenuation to distinguish fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis. Eur Respir J, 54 (1) 1900531; 10.1183/13993003.00531-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Imaging of eosinophilic lung disease
HISTOLOGICAL FINDINGS IN TRANSBRONCHIAL CRYOBIOPSIES OBTAINED FROM PATIENTS AFTER COVID-19
Related content which might interest you:
Distinguishing fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis
Source: International Congress 2019 – Lungs in the fog
Year: 2019
Small airways impairment and air-trapping distinguish chronic hypersensitivity pneumonitis (CHP) from idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017
Chronic hypersensitivity pneumonitis and its differential diagnosis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=189
Year: 2007
Procoagulant and antifibrynolitic activities strongly correlate with fibrosis and tissue turn-over markers in patients with active idiopathic pulmonary fibrosis and hypersensitivity pneumonitis
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008
The classification, natural history and radiological/histological appearance of idiopathic pulmonary fibrosis and the other idiopathic interstitial pneumonias
Source: Eur Respir Rev 2008; 17: 108-115
Year: 2008
Subtypes of pulmonary emphysema on HRCT affect prognosis on combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
PP217 – Modeling idiopathic pulmonary fibrosis on a lung-on-chip
Source: ERS Lung Science Conference 2021
Year: 2021
Exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2016 – Russia Session
Year: 2016
Ectopic subpleural fat deposition in idiopathic pulmonary fibrosis correlates with radiographic extension of fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease
Source: Eur Respir Rev 2009; 18: 129-132
Year: 2009
Distinctive polarization of circulating classical monocytes between idiopathic pulmonary fibrosis and idiopathic nonspecific interstitial pneumonia.
Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Year: 2020
Clinical features of usual interstitial pneumonia-correlation between idiopathic pulmonary fibrosis and connective tissue disease associated with usual interstitial pneumonia
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Significance of histopathologic features suggesting connective tissue disease in idiopathic pulmonary fibrosis
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Comparison between patients with idiopathic pulmonary fibrosis and patients with pulmonary involvement of the usual interstitial pneumonia pattern that preceded the onset of rheumatoid arthritis
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Idiopathic pulmonary upper lobe fibrosis shows distinct features and poor prognosis compared to idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
Inhibition of local fibrinolysis differs between idiopathic pulmonary fibrosis (IPF) and fibrotic non-specific interstitial pneumonia (f-NSIP)
Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms
Year: 2009
Expression of heat shock protein 47 in chronic hypersensitivity pneumonitis
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015
The role of pulmonary structural cells in pulmonary fibrosis in a model of hypersensitivity pneumonitis
Source: Annual Congress 2010 - Immune modulation of airways diseases
Year: 2010
Differences of acute exacerbations in idiopathic pulmonary fibrosis compared to other fibrotic lung diseases
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019
Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?
Source: Eur Respir J 2007; 30: 835-839
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept